Overview

Single Dose Truvada Study

Status:
Completed
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
This study examines tenofovir (TFV) drug concentrations in adults one day after taking a single dose of Truvada® - a pill used to prevent and treat HIV infection. The results of this study will be used to improve the (efficacy/accuracy) of a white coat adherence (WCA) detection test - a blood test that can be used to indicate medication adherence. Participants will receive one dose of Truvada®, and provide 2 total samples of blood.
Phase:
Phase 1
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Tenofovir